Beaver, J., Hazarika, M., Mulkey, F., Mushti, S., Chen, H., He, K., … Theoret, M. (2018). Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(17)30846-X (Original work published 2018)